These results, along with a previous report exhibiting that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 support the concept of targeting ACKR3 as a unique approach to modulate the opioid technique, which could open up new therapeutic avenues for opioid-linked Diseases. At that time, Microsoft Marketing https://miriamz949qhy6.blog2freedom.com/profile